Investment Group to Invest up to $35M into Accelr8; New CEO Tapped | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelr8 today announced an investment group plans to invest up to $35 million into the company to support further development and commercialization of its BACcel platform.

In conjunction with the investment, one member of the investment group will become Accelr8's CEO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.